Yoghurt Consumption, Body Weight Management and Glycemic Control of T2DM Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03926806 |
Recruitment Status :
Completed
First Posted : April 25, 2019
Last Update Posted : April 26, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Type 2 Diabetes Mellitus | Other: Plain yoghurt Other: Vitamin B yoghurt | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 33 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Parallel assignment |
Masking: | Double (Participant, Care Provider) |
Primary Purpose: | Treatment |
Official Title: | Effect of Dietary Intervention With Dairy Products (Yoghurt) on Body Weight Management and Glycemic Control of T2DM Patients |
Actual Study Start Date : | November 25, 2016 |
Actual Primary Completion Date : | August 8, 2018 |
Actual Study Completion Date : | December 29, 2018 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Plain yoghurt
2x200g plain yoghurt/day for 12 weeks
|
Other: Plain yoghurt
cups of 200 g yoghurt
Other Name: Conventional yoghurt |
Experimental: Vitamin B yoghurt
2x200g yoghurt enriched with vitamins B for 12 weeks
|
Other: Vitamin B yoghurt
cups of 200 g yoghurt |
- Body weight management [ Time Frame: 12 weeks ]Change of body weight after dietary intervention
- Glycemic control [ Time Frame: 12 weeks ]Change of fasting plasma glucose after dietary intervention
- Change of ghrelin response [ Time Frame: 12 weeks ]Change of ghrelin after the 12 weeks dietary intervention
- Change of GLP-1 response [ Time Frame: 12 weeks ]Change of GLP-1 after the 12 weeks dietary intervention

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 45 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- BMI 27-36
- HbA1C < 8.5%
- Constant body weight and dietary habits for the last 3 months
- Stable dose of oral medication for at least 3 months
- Diagnosed with T2DM for more than 1 year
Exclusion Criteria:
- History of cardiovascular, gastrointestinal, renal and endocrinological diseases
- Treatment for weight reduction
- Lactose intolerance
- Allergies to milk and dairy products
- Alcohol consumption (> 2 drinks per day)
- Intake of supplements
- Receiving insulin

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03926806
Principal Investigator: | Amalia Yanni | Harokopio University | |
Study Chair: | Nikolaos Tentolouris | National and Kapodistrian University of Athens | |
Study Director: | Vaios Karathanos | Harokopio University |
Responsible Party: | Amalia Yanni, Research and Teaching Associate-Staff, Harokopio University |
ClinicalTrials.gov Identifier: | NCT03926806 |
Other Study ID Numbers: |
1354.18-11-16 |
First Posted: | April 25, 2019 Key Record Dates |
Last Update Posted: | April 26, 2019 |
Last Verified: | April 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
yoghurt vitamins B body weight glycemic control |
Diabetes Mellitus, Type 2 Body Weight Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
Vitamins Vitamin B Complex Micronutrients Nutrients Growth Substances Physiological Effects of Drugs |